Cartalax 20mg × 10
Research-use disclaimer
All products are strictly for laboratory research and in-vitro studies, not for human consumption.
Description
Cartalax (LAX) is a peptide preparation for articular cartilage repair and soft tissue regeneration, suitable for cartilage wear and inflammation caused by sports injuries or degenerative diseases.
Effects
Promotes chondrocyte proliferation and matrix synthesis; inhibits the release of inflammatory factors in the joint cavity; accelerates the repair of ligaments, tendons and other soft tissues; reduces joint pain and stiffness; improves joint mobility and functional recovery; delays the progression of joint degenerative diseases.
Usage
2-3 times per week, 20mg (1 vial) each time, dissolved in saline for intramuscular or intra-articular injection. A course of 4-6 weeks is recommended. Adjust dosage and course according to physician's instructions.
Suitable for
Patients with articular cartilage wear or injury; sports enthusiasts and athletes; patients with early-stage osteoarthritis; those in need of soft tissue repair.
Not suitable for
Those allergic to any ingredient of Cartalax; individuals with severe liver or kidney dysfunction; those with active bleeding or coagulation disorders; pregnant women, nursing mothers, and minors under 16 years of age.
Ingredients
Cartalax (a synthetic peptide compound, molecular weight approximately 2000 Da), mannitol, phosphate buffer.
Storage
Store in a cool, dry place protected from light, sealed, at 2-8°C (refrigerated). Do not freeze.
Shelf life
24 months
Product research FAQ
What is this product intended for?
It is supplied strictly for laboratory research and in-vitro studies, not for human consumption.
Is batch documentation available?
Available batch-specific Certificates of Analysis are listed in the COA section on this page.
How should the product be stored?
Follow the storage information shown on this page and the instructions supplied with the specific batch.
